- Corporate Officers - B
- Belldegrun Arie
Insider Trading History of Belldegrun Arie
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Belldegrun Arie since 2007.
This trader's CIK number is 1296549.
At the time of last reporting, Belldegrun Arie was the Director of Allogene Therapeutics, Inc.. (stock ticker symbol ALLO).
Also see all insider trading activities at Allogene Therapeutics, Inc..
Note that in the past
Belldegrun Arie also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Allogene Therapeutics, Inc. (ALLO) by Belldegrun Arie
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | ALLO | 1,724,137 | $4,999,997 | 0 | $0 | 0 | $0 |
| 2022 | ALLO | 155,039 | $1,953,491 | 0 | $0 | 0 | $0 |
| 2021 | ALLO | 0 | $0 | 0 | $0 | 379,066 | $6,906,582 |
| 2020 | ALLO | 146,382 | $6,879,954 | 0 | $0 | 0 | $0 |
| 2018 | ALLO | 35,000 | $630,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Urogen Pharma Ltd. (URGN) by Belldegrun Arie
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | URGN | 0 | $0 | 0 | $0 | 163,241 | $816,205 |
| 2021 | URGN | 0 | $0 | 0 | $0 | 3,241 | $16,205 |
| 2019 | URGN | 0 | $0 | 0 | $0 | 128,000 | $514,559 |
Yearly summary of insider trading at Arno Therapeutics, Inc (ARNI) by Belldegrun Arie
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | ARNI | 2,876,632 | $756,821 | 0 | $0 | 0 | $0 |
| 2013 | ARNI | 479,164 | $0 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Kite Pharma, Inc. (KITE) by Belldegrun Arie
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | KITE | 17,000 | $1,165,690 | 26,347 | $4,733,607 | 0 | $0 |
| 2016 | KITE | 0 | $0 | 3,493 | $177,653 | 0 | $0 |
Yearly summary of insider trading at Srkp 4 Inc (CGRB) by Belldegrun Arie
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2008 | CGRB | 5,000 | $134,975 | 0 | $0 | 0 | $0 |
| 2007 | CGRB | 40,800 | $972,240 | 0 | $0 | 0 | $0 |
Insider trading activities at 5 companies by Belldegrun Arie:
1. Allogene Therapeutics, Inc. (ALLO)
2. Urogen Pharma Ltd. (URGN)
3. Arno Therapeutics, Inc (ARNI)
4. Kite Pharma, Inc. (KITE)
5. Srkp 4 Inc (CGRB)
Table 1. Insider trading of Allogene Therapeutics, Inc. (ALLO) by Belldegrun Arie
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-05-16 | ALLO | Buy | 1,724,137 | 2.90 | 4,999,997 |
| 2022-01-12 | ALLO | Buy | 155,039 | 12.60 | 1,953,491 |
| 2021-05-24 | ALLO | Option Ex | 379,066 | 18.22 | 6,906,582 |
| 2020-06-04 | ALLO | Buy | 146,382 | 47.00 | 6,879,954 |
| 2018-10-15 | ALLO | Buy | 35,000 | 18.00 | 630,000 |
Table 2. Insider trading of Urogen Pharma Ltd. (URGN) by Belldegrun Arie
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-09-14 | URGN | Option Ex | 160,000 | 5.00 | 800,000 |
| 2022-08-31 | URGN | Option Ex | 3,241 | 5.00 | 16,205 |
| 2021-03-24 | URGN | Option Ex | 3,241 | 5.00 | 16,205 |
| 2019-03-27 | URGN | Option Ex | 128,000 | 4.02 | 514,559 |
Table 3. Insider trading of Arno Therapeutics, Inc (ARNI) by Belldegrun Arie
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-08-15 | ARNI | Buy | 714,285 | .00 | 0 |
| 2016-01-12 | ARNI | Buy | 2,162,347 | .35 | 756,821 |
| 2013-10-29 | ARNI | Buy | 395,832 | .00 | 0 |
| 2013-10-29 | ARNI | Buy | 83,332 | .00 | 0 |
Table 4. Insider trading of Kite Pharma, Inc. (KITE) by Belldegrun Arie
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-09-25 | KITE | Sale | 26,347 | 179.66 | 4,733,607 |
| 2017-05-09 | KITE | Buy | 17,000 | 68.57 | 1,165,690 |
| 2016-12-20 | KITE | Sale | 3,493 | 50.86 | 177,653 |
Table 5. Insider trading of Srkp 4 Inc (CGRB) by Belldegrun Arie
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2008-02-21 | CGRB | Buy | 5,000 | 27.00 | 134,975 |
| 2007-12-18 | CGRB | Buy | 15,000 | 30.50 | 457,500 |
| 2007-06-18 | CGRB | Buy | 3,700 | 23.90 | 88,430 |
| 2007-05-08 | CGRB | Buy | 7,100 | 21.10 | 149,810 |
| 2007-02-26 | CGRB | Buy | 14,000 | 18.43 | 257,950 |
| 2007-02-27 | CGRB | Buy | 1,000 | 18.55 | 18,550 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Belldegrun Arie
(Director of Allogene Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.